Nicaragua vs Syria: The number of people with susceptibility test result for rifampicin
Nicaragua
627
in 2021
Syria
705
in 2021
Nicaragua rank
74th
Syria rank
71st
The number of people with susceptibility test result for rifampicin over time
- Nicaragua
- Syria
How they compare
Syria currently reports 705 against 627 in Nicaragua, a difference of 78.
That makes Syria's figure about 1.1 times Nicaragua's.
The two have swapped places 3 times across 5 shared years of data; in 2017 it was Nicaragua ahead.
Nicaragua ranks 74th and Syria ranks 71st of 155 countries.
Nicaragua has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Nicaragua | Syria | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 675.33 | 491.33 | 184 | Nicaragua |
| 2020s | 944.5 | 808.5 | 136 | Nicaragua |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Nicaragua or Syria?
- Syria, at 705 against 627 in Nicaragua as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Nicaragua and Syria?
- 78, with Syria ahead.
- How many years of comparable data are there for Nicaragua and Syria?
- 5 years are reported by both, from 2017 to 2021.
- How do Nicaragua and Syria rank globally for the number of people with susceptibility test result for rifampicin?
- Nicaragua ranks 74th and Syria ranks 71st of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.